Chemveda is a leading contract research, development and manufacturing organization in India and provides innovative development and manufacturing solutions to the global pharmaceutical industry.
As a global CDMO partner, Chemveda offers unique and specialized support for the effective transition from the Discovery chemistry phase to early tox, GLP tox, and scale-up – minimizing delays. After process development and optimization in PR&D laboratories, the technology is transferred to the manufacturing team through the Technology Transfer Team, which is led by DQA. We offer a wide range of manufacturing services from a few kilos to multi tons of GMP manufacturing of Key Starting Material (KSM) / Registered Starting Materials (RSM), advanced intermediates and APIs.
Chemveda has a scale-up manufacturing facility consisting of both Pilot and scale-up blocks. The multi-purpose manufacturing facility is designed to handle multiple products that demand a range of complex chemistries and operating conditions.
The manufacturing plant is accredited by ISO 9001:2015, GMP certification (CDSCO led
DGCI approved)
The Pilot lab consists of all-glass reactors ranging from 50L to 200L, along with 0.5KL, 1.0KL SSRs, and 0.63KL, 1.0KL GLRs. This block operates at temperatures from -80°C to 150°C. The Pilot lab also has a 25L autoclave capable of operating under high pressure (up to 20Kg) & high temperature (200°C).
Impurities generated during the degradation studies will be identified, characterized, and quantified using advanced analytical techniques. This information will support the establishment of impurity specifications, with the goal of providing a scientific rationale for relaxing impurity limits where appropriate. This approach ensures alignment with regulatory expectations while maintaining the safety, efficacy, and quality of the drug substance.
Available storage conditions:
Forced degradation studies of the drug substance will be conducted in accordance with ICH and ANVISA guidelines. These studies will provide a comprehensive understanding of the product’s stability and its degradation pathways under various stress conditions, including heat, light, oxidation, and hydrolysis. This approach ensures the development of a robust stability profile for the drug substance.
Expertise in handling the analytical method validations as per the regulatory guidelines like ICH and ANVISA, also offer method verifications to confirm the applicability and consistency of third-party methods in our facilities.
Our Quality Management System (QMS) is designed to ensure the highest standards of quality and compliance throughout our operations.